Clinical trial
Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination in Patients With Cystic Fibrosis and, Where Applicable, the Clinical Expression of Influenza A (H1N1)
NCT01499914 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination in Patients With Cystic Fibrosis and, Where Applicable, the Clinical Expression of Influenza A (H1N1)
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- December 31, 2012
- Enrollment
- 439 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis with gastrointestinal manifestation